Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIPD of Vancomycin in Adults
NCT05535075Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Gram-positive bacterial infection, sponsored by Ghent University Hospital. Started Nov 2021; status: completed.
02
Drugs
vancomycin
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT05535075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05535075.